Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
HI ›
HIXBIA
Trademark search for:
HIXBIA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-02-25 — Application filed
2016-03-31 — Sn assigned for sect 66a appl from ib
2016-04-06 — Application filed
2016-04-12 — Application filed
2016-04-13 — Application filed
2016-06-10 — Approved for pub - principal register
2016-06-10 — Assigned to examiner
2016-06-29 — Notice of publication
2016-06-29 — Notification of possible opposition sent to ib
2016-06-29 — Notice of start of opposition period created, to be sent to ib
2016-07-19 — Published for opposition
2016-10-04 — Registered-principal register
2016-11-03 — Grant of protection created, to be sent to ib
2017-01-11 — Final disposition recorded
2017-01-11 — Final disposition recorded
2017-01-26 — Notification processed by ib
2017-06-09 — Notification of possible opposition - processed by ib
2021-08-06 — Change of name/address rec'd from ib
2021-11-21 — New representative at ib received
2023-04-21 — Cancelled section 71
2023-04-21 — Final status recorded
2023-12-21 — Total invalidation of reg ext protection created
2024-01-07 — Total invalidation of reg ext protection sent to ib
2024-01-07 — Invalidation processed
2024-01-29 — Total invalidation processed by the ib
Owner Information
Novo Nordisk Health Care AG
CH
Novo Nordisk Health Care AG
CH
Novo Nordisk Health Care AG
CH
Correspondent
Isler & Pedrazzini AG Postfach 1772 CH-8027 Zürich, SWITZERLAND
Filing Details
Filing Date:
2016-02-25
Status Date:
2023-04-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.